Fibrosis Stage-Specific Incidence of Hepatocellular Cancer After Hepatitis C Cure With Direct-Acting Antivirals

Hepatitis C virus (HCV) eradication with direct-acting antivirals reduces hepatocellular carcinoma (HCC) risk.

A systematic review and meta-analysis, published in Clinical Gastroenterology and Hepatology, assessed HCC incidence or outcomes by cirrhosis status and fibrosis stage, in adults with HCV who achieved sustained virologic response after direct-acting antivirals (DAAs).

The study abstract can be accessed here.